Emergent BioSolutions (EBS) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Emergent BioSolutions (EBS) over the last 16 years, with Q3 2025 value amounting to $493.3 million.
- Emergent BioSolutions' Other Gross PP&E Adjustments fell 2520.09% to $493.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $493.3 million, marking a year-over-year decrease of 2520.09%. This contributed to the annual value of $656.0 million for FY2024, which is 1568.12% down from last year.
- Per Emergent BioSolutions' latest filing, its Other Gross PP&E Adjustments stood at $493.3 million for Q3 2025, which was down 2520.09% from $508.0 million recorded in Q2 2025.
- In the past 5 years, Emergent BioSolutions' Other Gross PP&E Adjustments ranged from a high of $1.2 billion in Q4 2022 and a low of $493.3 million during Q3 2025
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was $786.7 million (2024), whereas its average is $861.0 million.
- Per our database at Business Quant, Emergent BioSolutions' Other Gross PP&E Adjustments skyrocketed by 2678.48% in 2021 and then crashed by 3501.97% in 2025.
- Over the past 5 years, Emergent BioSolutions' Other Gross PP&E Adjustments (Quarter) stood at $1.1 billion in 2021, then increased by 8.35% to $1.2 billion in 2022, then crashed by 34.18% to $778.0 million in 2023, then decreased by 15.68% to $656.0 million in 2024, then fell by 24.8% to $493.3 million in 2025.
- Its last three reported values are $493.3 million in Q3 2025, $508.0 million for Q2 2025, and $511.2 million during Q1 2025.